Investors

Our investors recognize and applaud our mission to revolutionize healthcare by providing physicians with better tools. With our flagship innovation OtoSight, we’ve re-engineered a proven technology — Optical Coherence Tomography (OCT) — to significantly improve assessment, treatment, and monitoring of the middle ear infections.

Get In Touch

If you’d like to hear more about the OtoSight — or see it in action during a demo — let us know.

The OtoSight is FDA-cleared and in use at healthcare facilities across the country. Non-invasive, cost efficient and up to twice as accurate as existing otoscope technology, OtoSight is our flagship innovation

  • "OtoSight Middle Ear Scope's advanced light-based technology could dramatically alter the way children with ear problems are evaluated, enhancing our ability to inform optimal treatments."
    — Diego Preciado, M.D., Ph.D. of the Children's National Hospital in Washington, D.C.

Impactful Innovation

The OtoSight is FDA-cleared and in use at healthcare facilities across the country. Non-invasive, cost efficient and up to twice as accurate as existing otoscope technology, OtoSight is our flagship innovation.

Current Investors